{"entity":{"type":"insider","cik":"0001786335","url":"/insider/0001786335","json_url":"/insider/0001786335.json","name":"Horn Howard","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":20,"first":"2020-06-02","last":"2026-08-04","span_basis":"filed_date"},"name_variants":[{"name":"Horn Howard","source":"filing","n_filings":20,"first_seen":"2020-06-02","last_seen":"2026-08-04"}],"transactions":[{"id":6063466,"accession":"0001193125-26-332536","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-332536","line_url":"/filing/0001193125-26-332536#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4696.0,"shares_display":"4,696","price_per_share":24.92,"price_display":"24.92","price_state":"stated","total_value":117024.32,"total_display":"117,024.32","shares_owned_after":96295.0,"shares_owned_after_display":"96,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-03","filed_date":"2026-08-04","scope":"insider"},{"id":5897007,"accession":"0001193125-26-296128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-296128","line_url":"/filing/0001193125-26-296128#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4698.0,"shares_display":"4,698","price_per_share":33.13,"price_display":"33.13","price_state":"stated","total_value":155644.74,"total_display":"155,644.74","shares_owned_after":100991.0,"shares_owned_after_display":"100,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-06","scope":"insider"},{"id":5989649,"accession":"0001786335-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001786335-26-000002","line_url":"/filing/0001786335-26-000002#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4653.0,"shares_display":"4,653","price_per_share":23.77,"price_display":"23.77","price_state":"stated","total_value":110601.81,"total_display":"110,601.81","shares_owned_after":105689.0,"shares_owned_after_display":"105,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-01","scope":"insider"},{"id":6017288,"accession":"0001193125-26-204402","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-204402","line_url":"/filing/0001193125-26-204402#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4683.0,"shares_display":"4,683","price_per_share":24.9,"price_display":"24.90","price_state":"stated","total_value":116606.7,"total_display":"116,606.70","shares_owned_after":110342.0,"shares_owned_after_display":"110,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-04","scope":"insider"},{"id":6195576,"accession":"0001193125-26-140702","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-140702","line_url":"/filing/0001193125-26-140702#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4683.0,"shares_display":"4,683","price_per_share":20.97,"price_display":"20.97","price_state":"stated","total_value":98202.51,"total_display":"98,202.51","shares_owned_after":80351.0,"shares_owned_after_display":"80,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-02","scope":"insider"},{"id":6134105,"accession":"0001193125-26-089107","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-089107","line_url":"/filing/0001193125-26-089107#line-4","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1635.0,"shares_display":"1,635","price_per_share":22.4,"price_display":"22.40","price_state":"stated","total_value":36624.0,"total_display":"36,624.00","shares_owned_after":85034.0,"shares_owned_after_display":"85,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-03","scope":"insider"},{"id":6134101,"accession":"0001193125-26-089107","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-089107","line_url":"/filing/0001193125-26-089107#line-3","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5290.0,"shares_display":"5,290","price_per_share":22.8,"price_display":"22.80","price_state":"stated","total_value":120612.0,"total_display":"120,612.00","shares_owned_after":89788.0,"shares_owned_after_display":"89,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":6134099,"accession":"0001193125-26-089107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-089107","line_url":"/filing/0001193125-26-089107#line-2","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3119.0,"shares_display":"3,119","price_per_share":22.54,"price_display":"22.54","price_state":"stated","total_value":70302.26,"total_display":"70,302.26","shares_owned_after":86669.0,"shares_owned_after_display":"86,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":6035967,"accession":"0001193125-26-034832","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-034832","line_url":"/filing/0001193125-26-034832#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3061.0,"shares_display":"3,061","price_per_share":23.56,"price_display":"23.56","price_state":"stated","total_value":72117.16,"total_display":"72,117.16","shares_owned_after":88935.0,"shares_owned_after_display":"88,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-03","scope":"insider"},{"id":5821986,"accession":"0001193125-26-002410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-002410","line_url":"/filing/0001193125-26-002410#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3150.0,"shares_display":"3,150","price_per_share":22.84,"price_display":"22.84","price_state":"stated","total_value":71946.0,"total_display":"71,946.00","shares_owned_after":91996.0,"shares_owned_after_display":"91,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-05","scope":"insider"},{"id":4066687,"accession":"0001193125-25-315460","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-315460","line_url":"/filing/0001193125-25-315460#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3081.0,"shares_display":"3,081","price_per_share":36.38,"price_display":"36.38","price_state":"stated","total_value":112086.78,"total_display":"112,086.78","shares_owned_after":95146.0,"shares_owned_after_display":"95,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-10","filed_date":"2025-12-11","scope":"insider"},{"id":4701675,"accession":"0001193125-25-238708","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-238708","line_url":"/filing/0001193125-25-238708#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7942.0,"shares_display":"7,942","price_per_share":31.51,"price_display":"31.51","price_state":"stated","total_value":250252.42,"total_display":"250,252.42","shares_owned_after":98227.0,"shares_owned_after_display":"98,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-13","filed_date":"2025-10-14","scope":"insider"},{"id":5074000,"accession":"0000950170-25-036056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-036056","line_url":"/filing/0000950170-25-036056#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1785.0,"shares_display":"1,785","price_per_share":40.4,"price_display":"40.40","price_state":"stated","total_value":72114.0,"total_display":"72,114.00","shares_owned_after":106169.0,"shares_owned_after_display":"106,169","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-06","filed_date":"2025-03-10","scope":"insider"},{"id":2394040,"accession":"0000950170-24-114378","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-114378","line_url":"/filing/0000950170-24-114378#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7465.0,"shares_display":"7,465","price_per_share":52.76,"price_display":"52.76","price_state":"stated","total_value":393853.4,"total_display":"393,853.40","shares_owned_after":92301.0,"shares_owned_after_display":"92,301","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-10","filed_date":"2024-10-11","scope":"insider"},{"id":8651608,"accession":"0001209191-23-013007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-013007","line_url":"/filing/0001209191-23-013007#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (CFO)","officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2248.0,"shares_display":"2,248","price_per_share":25.973,"price_display":"25.97","price_state":"stated","total_value":58387.304,"total_display":"58,387.30","shares_owned_after":230712.0,"shares_owned_after_display":"230,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-23","filed_date":"2023-02-24","scope":"insider"},{"id":7830625,"accession":"0001209191-23-011382","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-011382","line_url":"/filing/0001209191-23-011382#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (CFO)","officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2424.0,"shares_display":"2,424","price_per_share":25.288,"price_display":"25.29","price_state":"stated","total_value":61298.112,"total_display":"61,298.11","shares_owned_after":232960.0,"shares_owned_after_display":"232,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-17","filed_date":"2023-02-21","scope":"insider"},{"id":6203936,"accession":"0001209191-22-011735","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-011735","line_url":"/filing/0001209191-22-011735#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (CFO)","officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2393.0,"shares_display":"2,393","price_per_share":31.9309,"price_display":"31.93","price_state":"stated","total_value":76410.6437,"total_display":"76,410.64","shares_owned_after":200384.0,"shares_owned_after_display":"200,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-17","filed_date":"2022-02-22","scope":"insider"},{"id":2141379,"accession":"0001209191-20-042489","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-042489","line_url":"/filing/0001209191-20-042489#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (CFO)","officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":50.0577,"price_display":"50.06","price_state":"stated","total_value":1501731.0,"total_display":"1,501,731.00","shares_owned_after":177777.0,"shares_owned_after_display":"177,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-13","filed_date":"2020-07-15","scope":"insider"},{"id":2832677,"accession":"0001209191-20-040660","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-040660","line_url":"/filing/0001209191-20-040660#line-4","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (CFO)","officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":400000.0,"total_display":"400,000.00","shares_owned_after":207777.0,"shares_owned_after_display":"207,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-02","filed_date":"2020-07-02","scope":"insider"},{"id":2832676,"accession":"0001209191-20-040660","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-040660","line_url":"/filing/0001209191-20-040660#line-3","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (CFO)","officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9100.0,"shares_display":"9,100","price_per_share":37.7225,"price_display":"37.72","price_state":"stated","total_value":343274.75,"total_display":"343,274.75","shares_owned_after":218677.0,"shares_owned_after_display":"218,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-02","scope":"insider"},{"id":2832674,"accession":"0001209191-20-040660","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-040660","line_url":"/filing/0001209191-20-040660#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (CFO)","officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":38.784,"price_display":"38.78","price_state":"stated","total_value":19392.0,"total_display":"19,392.00","shares_owned_after":218177.0,"shares_owned_after_display":"218,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-02","scope":"insider"},{"id":2832670,"accession":"0001209191-20-040660","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-040660","line_url":"/filing/0001209191-20-040660#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (CFO)","officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":39.33,"price_display":"39.33","price_state":"stated","total_value":15732.0,"total_display":"15,732.00","shares_owned_after":217777.0,"shares_owned_after_display":"217,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-02","scope":"insider"},{"id":2966871,"accession":"0001209191-20-039103","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-039103","line_url":"/filing/0001209191-20-039103#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (CFO)","officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","shares_owned_after":227777.0,"shares_owned_after_display":"227,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-25","filed_date":"2020-06-26","scope":"insider"},{"id":2111111,"accession":"0001209191-20-038511","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-038511","line_url":"/filing/0001209191-20-038511#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (CFO)","officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":400000.0,"total_display":"400,000.00","shares_owned_after":257777.0,"shares_owned_after_display":"257,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-19","filed_date":"2020-06-23","scope":"insider"},{"id":2544306,"accession":"0001209191-20-033779","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-033779","line_url":"/filing/0001209191-20-033779#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (CFO)","officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6714.0,"shares_display":"6,714","price_per_share":35.3847,"price_display":"35.38","price_state":"stated","total_value":237572.8758,"total_display":"237,572.88","shares_owned_after":267777.0,"shares_owned_after_display":"267,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-01","filed_date":"2020-06-02","scope":"insider"},{"id":2544302,"accession":"0001209191-20-033779","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-033779","line_url":"/filing/0001209191-20-033779#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786335","owner_name":"Horn Howard","owner_url":"/insider/0001786335","role":"Officer (CFO)","officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3286.0,"shares_display":"3,286","price_per_share":34.5299,"price_display":"34.53","price_state":"stated","total_value":113465.2514,"total_display":"113,465.25","shares_owned_after":274491.0,"shares_owned_after_display":"274,491","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-01","filed_date":"2020-06-02","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001515673","name":"Ultragenyx Pharmaceutical Inc.","url":"/issuer/0001515673","role":"Officer (Chief Financial Officer)","n_filings":12,"first_seen":"2024-10-11","last_seen":"2026-08-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001706431","name":"Vir Biotechnology, Inc.","url":"/issuer/0001706431","role":"Officer (CFO)","n_filings":8,"first_seen":"2020-06-02","last_seen":"2023-02-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001786335","retrieved_at":"2026-08-22T01:06:30+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}